| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
|
Nat Genet
|
1998
|
12.92
|
|
2
|
Scale for the assessment and rating of ataxia: development of a new clinical scale.
|
Neurology
|
2006
|
6.44
|
|
3
|
Intensive coordinative training improves motor performance in degenerative cerebellar disease.
|
Neurology
|
2009
|
2.33
|
|
4
|
The natural history of degenerative ataxia: a retrospective study in 466 patients.
|
Brain
|
1998
|
2.11
|
|
5
|
High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia.
|
Neurology
|
2006
|
2.09
|
|
6
|
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.
|
Neurology
|
2011
|
2.06
|
|
7
|
Oxidative stress in patients with Friedreich ataxia.
|
Neurology
|
2000
|
2.03
|
|
8
|
Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients.
|
Brain
|
2009
|
1.91
|
|
9
|
Prevalence of antigliadin antibodies in ataxia patients.
|
Neurology
|
2003
|
1.89
|
|
10
|
Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype.
|
Ann Neurol
|
1999
|
1.74
|
|
11
|
Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect.
|
Neurology
|
2011
|
1.58
|
|
12
|
The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity.
|
Neurology
|
2006
|
1.54
|
|
13
|
Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
|
Neurology
|
2008
|
1.53
|
|
14
|
Double-blind crossover trial of trimethoprim-sulfamethoxazole in spinocerebellar ataxia type 3/Machado-Joseph disease.
|
Arch Neurol
|
2001
|
1.42
|
|
15
|
Spinocerebellar ataxia type 6: evidence for a strong founder effect among German families.
|
Neurology
|
1999
|
1.39
|
|
16
|
Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia.
|
Hum Mutat
|
2002
|
1.38
|
|
17
|
The aetiology of sporadic adult-onset ataxia.
|
Brain
|
2002
|
1.34
|
|
18
|
Frequency and phenotype of SPG11 and SPG15 in complicated hereditary spastic paraplegia.
|
J Neurol Neurosurg Psychiatry
|
2009
|
1.26
|
|
19
|
Differential stability of the (GAA)n tract in the Friedreich ataxia (STM7) gene.
|
Hum Genet
|
1997
|
1.22
|
|
20
|
An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients.
|
Brain Pathol
|
1998
|
1.17
|
|
21
|
Responsiveness of different rating instruments in spinocerebellar ataxia patients.
|
Neurology
|
2010
|
1.15
|
|
22
|
Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers.
|
Neurology
|
2001
|
1.09
|
|
23
|
SCA6 is caused by moderate CAG expansion in the alpha1A-voltage-dependent calcium channel gene.
|
Hum Mol Genet
|
1997
|
1.04
|
|
24
|
Motor fibers in the sural nerve of humans.
|
Neurology
|
1997
|
1.03
|
|
25
|
SPG10 is a rare cause of spastic paraplegia in European families.
|
J Neurol Neurosurg Psychiatry
|
2008
|
1.02
|
|
26
|
Prospective analysis of falls in dominant ataxias.
|
Eur Neurol
|
2012
|
1.00
|
|
27
|
SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia.
|
Neurology
|
2008
|
1.00
|
|
28
|
Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients.
|
Neuroreport
|
2000
|
0.98
|
|
29
|
Mitochondrial impairment of human muscle in Friedreich ataxia in vivo.
|
Neuromuscul Disord
|
2000
|
0.97
|
|
30
|
EFNS guidelines on the molecular diagnosis of mitochondrial disorders.
|
Eur J Neurol
|
2009
|
0.97
|
|
31
|
Genetic analysis of immunomodulating factors in sporadic Parkinson's disease.
|
J Neural Transm (Vienna)
|
2000
|
0.95
|
|
32
|
Consensus paper: management of degenerative cerebellar disorders.
|
Cerebellum
|
2014
|
0.95
|
|
33
|
Quantitative assessment of brain stem and cerebellar atrophy in spinocerebellar ataxia types 3 and 6: impact on clinical status.
|
AJNR Am J Neuroradiol
|
2011
|
0.93
|
|
34
|
EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders.
|
Eur J Neurol
|
2011
|
0.93
|
|
35
|
Polymorphisms of the alpha-synuclein promoter: expression analyses and association studies in Parkinson's disease.
|
J Neural Transm (Vienna)
|
2003
|
0.92
|
|
36
|
EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias.
|
Eur J Neurol
|
2009
|
0.91
|
|
37
|
Baroreflex sensitivity and power spectral analysis in different extrapyramidal syndromes.
|
J Neural Transm (Vienna)
|
2008
|
0.90
|
|
38
|
EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias.
|
Eur J Neurol
|
2009
|
0.90
|
|
39
|
Neurophysiological findings in SPG4 patients differ from other types of spastic paraplegia.
|
Neurology
|
2003
|
0.90
|
|
40
|
Prion mutation D178N with highly variable disease onset and phenotype.
|
J Neurol Neurosurg Psychiatry
|
2009
|
0.89
|
|
41
|
Degeneration of ingestion-related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7.
|
Neuropathol Appl Neurobiol
|
2006
|
0.89
|
|
42
|
Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico-pathological insights.
|
Neuropathol Appl Neurobiol
|
2012
|
0.88
|
|
43
|
Age related axonal neuropathy in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD).
|
J Neurol Neurosurg Psychiatry
|
1999
|
0.88
|
|
44
|
Pathoanatomy of cerebellar degeneration in spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3).
|
Cerebellum
|
2012
|
0.88
|
|
45
|
SCA2 trinucleotide expansion in German SCA patients.
|
Neurogenetics
|
1997
|
0.87
|
|
46
|
Polymorphisms in the PMP-22 gene region (17p11.2-12) are crucial for simplified diagnosis of duplications/deletions.
|
Hum Genet
|
1997
|
0.87
|
|
47
|
L-2 hydroxyglutaric aciduria as a rare cause of leukencephalopathy in adults.
|
Clin Neurol Neurosurg
|
2012
|
0.86
|
|
48
|
Heterozygous expansion of the GAA tract of the X25/frataxin gene is associated with insulin resistance in humans.
|
Diabetes
|
2000
|
0.86
|
|
49
|
The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia.
|
J Mol Med (Berl)
|
2001
|
0.86
|
|
50
|
Transmission distortion of the mutant alleles in spinocerebellar ataxia.
|
Hum Genet
|
1997
|
0.84
|
|
51
|
Autosomal dominant spastic paraplegia with peripheral neuropathy maps to chr12q23-24.
|
Neurology
|
2009
|
0.84
|
|
52
|
Machado-Joseph disease mutations as the genetic basis of most spinocerebellar ataxias in Germany.
|
J Neurol Neurosurg Psychiatry
|
1995
|
0.84
|
|
53
|
Valsalva manoeuvre in patients with different Parkinsonian disorders.
|
J Neural Transm (Vienna)
|
2009
|
0.83
|
|
54
|
Association of moderate polyglutamine tract expansions in the slow calcium-activated potassium channel type 3 with ataxia.
|
Arch Neurol
|
2001
|
0.83
|
|
55
|
Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2).
|
Acta Neuropathol
|
2005
|
0.82
|
|
56
|
Mutations in the PDYN gene (SCA23) are not a frequent cause of dominant ataxia in Central Europe.
|
Clin Genet
|
2011
|
0.82
|
|
57
|
The dopamine D2 receptor (DRD2) gene-a genetic risk factor in heavy smoking?
|
Addict Biol
|
2000
|
0.81
|
|
58
|
Mutation analysis and association studies of nuclear factor-kappaB1 in sporadic Parkinson's disease patients.
|
J Neural Transm (Vienna)
|
2002
|
0.81
|
|
59
|
Spinocerebellar ataxia type 6 (SCA6): neurodegeneration goes beyond the known brain predilection sites.
|
Neuropathol Appl Neurobiol
|
2009
|
0.81
|
|
60
|
Effective thalamic deep brain stimulation for neuropathic tremor in a patient with severe demyelinating neuropathy.
|
J Neurol Neurosurg Psychiatry
|
2009
|
0.81
|
|
61
|
Disease severity affects quality of life of hereditary spastic paraplegia patients.
|
Eur J Neurol
|
2011
|
0.81
|
|
62
|
Spinocerebellar ataxias types 2 and 3: degeneration of the pre-cerebellar nuclei isolates the three phylogenetically defined regions of the cerebellum.
|
J Neural Transm (Vienna)
|
2005
|
0.81
|
|
63
|
Transcranial sonography in spinocerebellar ataxia type 3.
|
J Neural Transm Suppl
|
2004
|
0.81
|
|
64
|
The cold hand sign in multiple system atrophy: skin perfusion revisited.
|
J Neural Transm (Vienna)
|
2010
|
0.80
|
|
65
|
Damage to the reticulotegmental nucleus of the pons in spinocerebellar ataxia type 1, 2, and 3.
|
Neurology
|
2004
|
0.80
|
|
66
|
Vertebral body infarction indicating midthoracic spinal stroke.
|
Spinal Cord
|
2002
|
0.80
|
|
67
|
Involvement of the auditory brainstem system in spinocerebellar ataxia type 2 (SCA2), type 3 (SCA3) and type 7 (SCA7).
|
Neuropathol Appl Neurobiol
|
2008
|
0.79
|
|
68
|
Spinocerebellar ataxia type 7 (SCA7): widespread brain damage in an adult-onset patient with progressive visual impairments in comparison with an adult-onset patient without visual impairments.
|
Neuropathol Appl Neurobiol
|
2007
|
0.79
|
|
69
|
Is the sural nerve a pure sensory nerve?
|
Muscle Nerve
|
2000
|
0.79
|
|
70
|
EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias.
|
Eur J Neurol
|
2010
|
0.79
|
|
71
|
Evaluation of the gamma-synuclein gene in German Parkinson's disease patients.
|
Neurosci Lett
|
2001
|
0.78
|
|
72
|
Spinocerebellar ataxia type 7 (SCA7): first report of a systematic neuropathological study of the brain of a patient with a very short expanded CAG-repeat.
|
Brain Pathol
|
2005
|
0.78
|
|
73
|
Head tremor due to bilateral thalamic and midbrain infarction.
|
J Neurol
|
1995
|
0.78
|
|
74
|
Primary central nervous system vasculitis in a child mimicking parasitosis.
|
J Neurol
|
2008
|
0.78
|
|
75
|
Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome.
|
Eur Neurol
|
1994
|
0.77
|
|
76
|
Leukodystrophies underlying cryptic spastic paraparesis: frequency and phenotype in 76 patients.
|
Eur J Neurol
|
2014
|
0.77
|
|
77
|
Analysis of the parkin deletion in sporadic and familial Parkinson's disease. Short communication.
|
J Neural Transm (Vienna)
|
1999
|
0.77
|
|
78
|
Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument.
|
Cerebellum
|
2013
|
0.76
|
|
79
|
Fact and fallacy in clinical and electrophysiological studies of anomalous innervation of the intrinsic foot muscles.
|
Muscle Nerve
|
1996
|
0.76
|
|
80
|
Extended pathoanatomical studies point to a consistent affection of the thalamus in spinocerebellar ataxia type 2.
|
Neuropathol Appl Neurobiol
|
2005
|
0.76
|
|
81
|
Modulation of disease risk according to a cathepsin D / apolipoprotein E genotype in Parkinson's disease.
|
J Neural Transm (Vienna)
|
2003
|
0.75
|
|
82
|
Reversible urinary retention as the main symptom in the first manifestation of a syringomyelia.
|
J Neurol Neurosurg Psychiatry
|
1996
|
0.75
|
|
83
|
Apomorphine--test in dystonia.
|
J Neural Transm Park Dis Dement Sect
|
1991
|
0.75
|
|
84
|
Collision technique in Martin-Gruber anastomosis.
|
Muscle Nerve
|
1998
|
0.75
|
|
85
|
Regular insulin secretory oscillations despite impaired ATP synthesis in Friedreich Ataxia patients.
|
Horm Metab Res
|
2006
|
0.75
|
|
86
|
[Drug-induced rhabdomyolysis and lesions of peripheral nerves. Sequelae of local ischemia within the scope of circulatory collapse?].
|
Nervenarzt
|
1996
|
0.75
|
|
87
|
Repeat length and disease progression in spinocerebellar ataxia type 3.
|
Lancet
|
1996
|
0.75
|
|
88
|
[Rare differential diagnosis of primary adrenal insufficiency: case 6/2011].
|
Dtsch Med Wochenschr
|
2011
|
0.75
|
|
89
|
Genetic analysis of the alpha2-macroglobulin gene in early- and late-onset Parkinson's disease.
|
Neuroreport
|
2000
|
0.75
|
|
90
|
Continuous subcutaneous lisuride infusion in OPCA.
|
J Neural Transm Gen Sect
|
1992
|
0.75
|
|
91
|
[Cardiomyopathy in Friedreich's ataxia].
|
Dtsch Med Wochenschr
|
1992
|
0.75
|